Prelude Capital Management’s Syndax Pharmaceuticals SNDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-32,739	Closed	-$504K	–	1536
2025 Q3	$504K	Sell	32,739 -57,094	-64%	-$747K	0.04%	506
2025 Q2	$841K	Sell	89,833 -1,884	-2%	-$20.7K	0.08%	299
2025 Q1	$1.13M	Buy	91,717 +5,492	+6%	+$77.5K	0.09%	280
2024 Q4	$1.14M	Buy	+86,225	New	+$1.48M	0.07%	349
2023 Q2	–	Sell	-10,943	Closed	-$231K	–	1330
2023 Q1	$231K	Buy	+10,943	New	+$272K	0.01%	785
2020 Q4	–	Sell	-300	Closed	-$4K	–	1919
2020 Q3	$4K	Buy	+300	New	+$4.57K	﹤0.01%	1596
2018 Q2	–	Sell	-71,938	Closed	-$1.02M	–	1924
2018 Q1	$1.02M	Buy	71,938 +39,572	+122%	+$420K	0.07%	276
2017 Q4	$284K	Buy	+32,366	New	+$320K	0.02%	540
2017 Q2	–	Sell	-28,742	Closed	-$394K	–	1828
2017 Q1	$394K	Buy	+28,742	New	+$298K	0.04%	370